<DOC>
	<DOCNO>NCT00004554</DOCNO>
	<brief_summary>This study examine depress alcoholic outpatient ass whether combine naltrexone ( Revia ) sertraline ( Zoloft ) result great reduction drink depression either medication alone placebo . A secondary aim determine whether certain patient feature predict response sertraline , naltrexone combination two drug . Subjects randomize treatment group 14 week . The followup phase include two visit 6 9 month treatment .</brief_summary>
	<brief_title>Sertraline Alcohol Dependence Depression</brief_title>
	<detailed_description>The propose study examine manage relapse patient alcohol dependence depression use 14-week double-blind , placebo-controlled , combination 100 mg/day naltrexone , 200 mg/day sertraline , individual , cognitive behavioral therapy ( CBT ) . For test medication , design 2x2 , consist four group : naltrexone/sertraline , naltrexone , sertraline , placebo . All four group receive weekly session CBT give therapist experience work patient substance disorder train principle CBT .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Male female outpatient 18 75 year age . Patients must meet DSMIV criterion ( primary substanceinduced ) major depressive episode prior randomization . Patients must current DSMIV diagnosis alcohol dependence . Patients must total score 10 high Hamilton Depression Scaleat day randomization . Also , item 1 scale must &gt; 1 . Patients must drink sufficient alcohol month prior come treatment practical assessment reduction drink treatment perform . The guideline follow study think sufficient patient month prior come treatment drink 40 % day drink 40 standard drink ( average 10 drink per week ) . Patients must successfully complete medical detoxification alcohol ( abstinent 4 consecutive day ) medical detoxification indicate , abstinent 4 consecutive day since coming treatment initiate study medication/placebo . Females childbearing potential must negative pregnancy test contemplating pregnancy within next 6 month . They must also use contraceptive method judge investigator effective . Patients evidence opiate use past 30 day assess selfreport intake urine drug screen ( one repeat test permit ) . Patients history treatment opiate dependence exclude . Patients , within past year , meet DSM IV criterion dependence psychoactive substance alcohol nicotine . Patients test positive urine drug screen ( exception THC ) initial visit ( one repeat test permit ) . Patients meet DSMIV criterion past history current disorder schizophrenia psychotic disorder , bipolar disorder . Patients evidence history significant hematological , pulmonary , endocrine , cardiovascular , renal gastrointestinal disease . ( If history disease condition stable one year judge investigator interfere patient 's participation study , patient may include . ) Patients abnormal liver function test ( AST ALT ) ( 3.5 time upper level normal value ) patient abnormal elevation bilirubin . Patients require concomitant therapy psychotropic drug ( exception benadryl use sparingly necessary sleep oxeazepam detoxification nicotine replacement therapy ) . Patients take fluoxetine ( Prozac ) 6 week prior randomization due long halflife . Patients take monoamine oxidase inhibitor ( MAOI ) 2 week prior randomization due potential toxicity combine MAOI medication serotoninspecific one . ( Patients also instruct take MAOI 2 week complete study . ) Past use antidepressant psychotropic medication ( except specify ) within 7 day randomization . Patients concomitant therapy investigational drug , patient investigational drug study within one month prior enter study . Patients unable read print English .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>